ConductScience.org, home

Paper30174151

Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors.

Hymel D and 4 others. Bioorg Med Chem Lett, 2018. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors. Papers, record 30174151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30174151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors.
PubMed
Journal
Bioorg Med Chem Lett
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hymel DDavid
2Grant RARobert A
3Tsuji KKohei
4Yaffe MBMichael B
5Burke TR JrTerrence R

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Cycle ProteinsMajor topic
HistidineMajor topic
Macrocyclic CompoundsMajor topic
Protein Serine-Threonine KinasesMajor topic
Proto-Oncogene ProteinsMajor topic
Cyclization
Enzyme-Linked Immunosorbent Assay
Polo-Like Kinase 1

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P41 GM103403NIGMS NIH HHSUnited StatesP41GM103403PubMed and NIHNIH RePORTER
R01 ES015339NIEHS NIH HHSUnited StatesR01ES015339PubMed and NIHNIH RePORTER
R35 ES028374NIEHS NIH HHSUnited StatesR35ES028374PubMed and NIHNIH RePORTER
R01 GM104047NIGMS NIH HHSUnited StatesR01GM104047PubMed and NIHNIH RePORTER
Z01 BC006198Intramural NIH HHSUnited StatesZIABC006198PubMed and NIHNIH RePORTER

Download CSV of grants

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127017542Small molecules that target phosphorylation dependent protein-protein interaction.Bioorg Med Chem2016https://conductscience.org/library/papers/27017542PubMed
225814554Phospho-tyrosine dependent protein-protein interaction network.Mol Syst Biol2015https://conductscience.org/library/papers/25814554PubMed
322570300Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1.Chembiochem2012https://conductscience.org/library/papers/22570300PubMed
419597481Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.Nat Struct Mol Biol2009https://conductscience.org/library/papers/19597481PubMed
528285924Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.Bioorg Med Chem2017https://conductscience.org/library/papers/28285924PubMed
626119925Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.Angew Chem Int Ed Engl2015https://conductscience.org/library/papers/26119925PubMed
727624074Application of oxime-diversification to optimize ligand interactions within a cryptic pocket of the polo-like kinase 1 polo-box domain.Bioorg Med Chem Lett2016https://conductscience.org/library/papers/27624074PubMed
824827688Design and synthesis of Fmoc-Thr[PO(OH)(OPOM)] for the preparation of peptide prodrugs containing phosphothreonine in fully protected form.Chem Biodivers2014https://conductscience.org/library/papers/24827688PubMed
925283071Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells.Biopolymers2014https://conductscience.org/library/papers/25283071PubMed
1026152807Neighbor-directed histidine N (τ)-alkylation: A route to imidazolium-containing phosphopeptide macrocycles.Biopolymers2015https://conductscience.org/library/papers/26152807PubMed
1127718641Discovery and optimization of peptide macrocycles.Expert Opin Drug Discov2016https://conductscience.org/library/papers/27718641PubMed
1228721210Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents.F1000Res2017https://conductscience.org/library/papers/28721210PubMed
1322292814Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification.ACS Chem Biol2012https://conductscience.org/library/papers/22292814PubMed
1426478211Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.Trends Pharmacol Sci2015https://conductscience.org/library/papers/26478211PubMed
1525664609Targeting protein-protein interfaces using macrocyclic peptides.Biopolymers2015https://conductscience.org/library/papers/25664609PubMed
1614532005The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.Cell2003https://conductscience.org/library/papers/14532005PubMed
1723159568Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1).Bioorg Med Chem Lett2012https://conductscience.org/library/papers/23159568PubMed
1822743087Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position.Bioorg Med Chem2013https://conductscience.org/library/papers/22743087PubMed
1923907438
Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.
Amino Acids2013https://conductscience.org/library/papers/23907438PubMed
2025211362Design and synthesis of a cell-permeable, drug-like small molecule inhibitor targeting the polo-box domain of polo-like kinase 1.PLoS One2014https://conductscience.org/library/papers/25211362PubMed

See all 31 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
39764864Fine-tuning probes for fluorescence polarization binding assays of bivalent ligands against polo-like kinase 1 using full-length protein.Bioorg Med Chem2025https://conductscience.org/library/papers/39764864PubMed
39092437Affinity enhancement of polo-like kinase 1 polo box domain-binding ligands by a bivalent approach using a covalent kinase-binding component.RSC Chem Biol2024https://conductscience.org/library/papers/39092437PubMed
38393054Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study.Mar Drugs2024https://conductscience.org/library/papers/38393054PubMed
36067356Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy.J Med Chem2022https://conductscience.org/library/papers/36067356PubMed
35408522Insights on the Synthesis of N-Heterocycles Containing Macrocycles and Their Complexion and Biological Properties.Molecules2022https://conductscience.org/library/papers/35408522PubMed
35029981Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1.J Med Chem2022https://conductscience.org/library/papers/35029981PubMed
34346472Design and synthesis of a new orthogonally protected glutamic acid analog and its use in the preparation of high affinity polo-like kinase 1 polo-box domain - binding peptide macrocycles.Org Biomol Chem2021https://conductscience.org/library/papers/34346472PubMed
33842469Regulation of the SIAH2-HIF-1 Axis by Protein Kinases and Its Implication in Cancer Therapy.Front Cell Dev Biol2021https://conductscience.org/library/papers/33842469PubMed
31014020Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors.Molecules2019https://conductscience.org/library/papers/31014020PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGXT189PubTator's text mininghttps://conductscience.org/library/genes/189NCBI Gene
HAL3034PubTator's text mininghttps://conductscience.org/library/genes/3034NCBI Gene
PLK15347PubTator's text mininghttps://conductscience.org/library/genes/5347NCBI Gene
PLK210769PubTator's text mininghttps://conductscience.org/library/genes/10769NCBI Gene
PLK31263PubTator's text mininghttps://conductscience.org/library/genes/1263NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30174151

GET https://conductscience.org/api/papers/v1/30174151/references?page=2